{"id":749654,"date":"2023-04-20T09:36:02","date_gmt":"2023-04-20T13:36:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\/"},"modified":"2023-04-20T09:36:02","modified_gmt":"2023-04-20T13:36:02","slug":"ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\/","title":{"rendered":"GE HealthCare\u2019s CARESCAPE Canvas Patient Monitoring Platform Receives FDA Clearance"},"content":{"rendered":"<p>        <!--.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p>\nGE HealthCare\u2019s CARESCAPE Canvas Patient Monitoring Platform Receives FDA Clearance<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nCARESCAPE Canvas builds on GE HealthCare\u2019s 50+ years of clinical excellence and provides a unified patient monitoring solution that is reliable, flexible, scalable and intuitive to use<\/p>\n<\/li>\n<\/ul>\n<p>CHICAGO&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nGE HealthCare (Nasdaq: GEHC) today announced US FDA 510(k) clearance of its <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.gehealthcare.com%2Fproducts%2Fpatient-monitoring%2Fpatient-monitors%2Fcarescape-canvas&amp;esheet=53384752&amp;newsitemid=20230420005615&amp;lan=en-US&amp;anchor=CARESCAPE+Canvas&amp;index=1&amp;md5=153c93c56f55eda75124da99b5c5697c\">CARESCAPE Canvas<\/a> patient monitoring platform for precise, flexible patient care. CARESCAPE Canvas and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.gehealthcare.com%2Fproducts%2Fpatient-monitoring%2Fpatient-monitors%2Fcarescape-one&amp;esheet=53384752&amp;newsitemid=20230420005615&amp;lan=en-US&amp;anchor=CARESCAPE+ONE&amp;index=2&amp;md5=27ce98bb360e34fd282a8c7acaba070f\">CARESCAPE ONE<\/a> are part of an adaptable ecosystem that can easily scale up and scale down monitoring capabilities based on the acuity of each individual patient, delivered on a standardized platform that drives enterprise efficiency and ease of service.<\/p>\n<p id=\"news-body-cta\">This press release features multimedia. View the full release here: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20230420005615\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20230420005615\/en\/<\/a><\/p>\n<div id=\"bwbodyimg\" style=\"width: 480px;float:left;padding-left:0px;padding-right:20px;padding-top:0px;padding-bottom:0px\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230420005615\/en\/1769739\/4\/MS-CARESCAPE-Canvas-NICU.jpg\" alt=\"CARESCAPE Canvas in the NICU (Photo: Business Wire)\" \/><\/p>\n<p style=\"font-size:85%\">CARESCAPE Canvas in the NICU (Photo: Business Wire)<\/p>\n<\/div>\n<p>\n\u201cAs patient acuity and disease trends change rapidly, adaptability in the hospital setting is becoming more important. We look for ways to improve the care experience by delivering quality clinical measurements where and when they are needed, giving care providers the information they need to make the best possible clinical decisions,\u201d Dr. Roland Schrewe, head of PICU, University of Frankfurt. \u201cGE HealthCare\u2019s CARESCAPE Canvas provides a precise, standardized and flexible patient monitoring solution that adapts to patient needs with the ease of switching out a cable.\u201d<\/p>\n<p>\nCARESCAPE Canvas is a FlexAcutity solution equipped with smart parameter technology that can be used for patients at all levels of acuity. This monitoring platform offers flexibility, standardization and ease of use by leveraging micromodules that connect with standardized medical USB technology &#8212; simply adding or disconnecting cables equipped for various configurations enables more efficient care based on patient care needs. It is also equipped with flexible, easy to configure software and interchangeable frames for advanced parameters, enable monitoring devices to be quickly redeployed across the hospital enterprise as needed.<\/p>\n<p>\n\u201cThis new monitoring ecosystem has the potential for a hospital to have one single unified approach to patient monitoring that can be easily tailored for each patient,\u201d said Neal Sandy, general manager, monitoring solutions, GE HealthCare. \u201cGE HealthCare is committed to offering flexible solutions that enable care teams to focus on the patient, not the technology. CARESCAPE Canvas\u2019 innovative approach, where software and patient parameters can change in a very nimble manner, enable a standardized ecosystem that can adapt to changing healthcare needs.\u201d<\/p>\n<p>\nThe CARESCAPE Canvas bedside monitor was developed and tested with the rest of GE HealthCare\u2019s ecosystem, not only with the current devices available, but also with prior versions that are used across the 100 million patients monitored by GE HealthCare devices each year. This backward compatibility allows healthcare systems to upgrade to the latest capabilities at their pace. CARESCAPE Canvas was also developed with sustainability in mind, with a 53% reduction in packaging volume<sup>1<\/sup>, 48% reduction in packaging weight compared to previous generation monitor<sup>1<\/sup>, and a 25% reduction in energy consumption compared to previous models<sup>2<\/sup>. In addition, CARESCAPE Canvas monitors made at GE HealthCare\u2019s Helsinki site are manufactured by using 100% renewable wind electricity<sup>3<\/sup>.<\/p>\n<p>\nCARESCAPE Canvas was recently awarded the world-renowned, iF Design Award 2023. The jury prize honors design achievements in all disciplines and recognized CARESCAPE Canvas for product design in medicine\/health.<\/p>\n<p>\nCARESCAPE Canvas has been approved for use in the EU since June, 2022 and is now cleared for use in the US.<\/p>\n<p><b>ABOUT GE HEALTHCARE TECHNOLOGIES INC.<\/b><\/p>\n<p>\nGE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient\u2019s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from prevention and screening, to diagnosis, treatment, therapy, and monitoring. We are an $18 billion business with 50,000 employees working to create a world where healthcare has no limits.<\/p>\n<p><i>Follow us on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FGEHealthcare%2F&amp;esheet=53384752&amp;newsitemid=20230420005615&amp;lan=en-US&amp;anchor=Facebook&amp;index=3&amp;md5=f6467dc71432d196557e2d4aec02ae1f\">Facebook<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fgehealthcare&amp;esheet=53384752&amp;newsitemid=20230420005615&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=4&amp;md5=ce4142474d73a6cee7b321db9c9fa1e8\">LinkedIn<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FGEHealthcare&amp;esheet=53384752&amp;newsitemid=20230420005615&amp;lan=en-US&amp;anchor=Twitter&amp;index=5&amp;md5=1b5086f7f154c1cf6924fa7de0c53195\">Twitter<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Fgehealthcare%2F&amp;esheet=53384752&amp;newsitemid=20230420005615&amp;lan=en-US&amp;anchor=Instagram&amp;index=6&amp;md5=bc886022afcabff79204277ad4af4f2e\">Instagram<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.gehealthcare.com%2Finsights&amp;esheet=53384752&amp;newsitemid=20230420005615&amp;lan=en-US&amp;anchor=Insights&amp;index=7&amp;md5=91678ed20ecee2e8c769aa28dfb2488c\">Insights<\/a> for the latest news, or visit our website <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.gehealthcare.com%2F&amp;esheet=53384752&amp;newsitemid=20230420005615&amp;lan=en-US&amp;anchor=www.gehealthcare.com&amp;index=8&amp;md5=dee6c47381fcc1b4a7e7858525783855\">www.gehealthcare.com<\/a> for more information.<\/i><\/p>\n<p><i>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/i><\/p>\n<p><sup>1<\/sup> CARESCAPE Canvas package is 53% smaller and packaging material mass is 48% lighter than the packaging of the equivalent CARESCAPE B850 monitor.<br \/>\n<br \/><sup>2<\/sup> CARESCAPE Canvas 1000 system uses 255 less energy than the CARESCAPE B850 system with the same setup.<br \/>\n<br \/><sup>3<\/sup> CARESCAPE Canvas 1000 is produced in Finland with renewable wind energy.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230420005615r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20230420005615\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20230420005615\/en\/<\/a><\/span><\/p>\n<p><b>GE HealthCare Media Contact:<br \/>\n<\/b><br \/>Jennifer Purdue<br \/>\n<br \/>M +1 267 593 9735<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:jennifer.purdue@ge.com\">jennifer.purdue@ge.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Illinois United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Technology FDA Health Radiology Oncology Neurology Health Technology Medical Devices Software Hardware<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230420005615\/en\/1673594\/3\/GE_HealthCare_Logo_%28Jan_2023%29.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230420005615\/en\/1769739\/3\/MS-CARESCAPE-Canvas-NICU.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">CARESCAPE Canvas in the NICU (Photo: Business Wire)<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>GE HealthCare\u2019s CARESCAPE Canvas Patient Monitoring Platform Receives FDA Clearance CARESCAPE Canvas builds on GE HealthCare\u2019s 50+ years of clinical excellence and provides a unified patient monitoring solution that is reliable, flexible, scalable and intuitive to use CHICAGO&#8211;(BUSINESS WIRE)&#8211; GE HealthCare (Nasdaq: GEHC) today announced US FDA 510(k) clearance of its CARESCAPE Canvas patient monitoring platform for precise, flexible patient care. CARESCAPE Canvas and CARESCAPE ONE are part of an adaptable ecosystem that can easily scale up and scale down monitoring capabilities based on the acuity of each individual patient, delivered on a standardized platform that drives enterprise efficiency and ease of service. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20230420005615\/en\/ CARESCAPE Canvas in the NICU (Photo: &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;GE HealthCare\u2019s CARESCAPE Canvas Patient Monitoring Platform Receives FDA Clearance&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-749654","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GE HealthCare\u2019s CARESCAPE Canvas Patient Monitoring Platform Receives FDA Clearance - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GE HealthCare\u2019s CARESCAPE Canvas Patient Monitoring Platform Receives FDA Clearance - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"GE HealthCare\u2019s CARESCAPE Canvas Patient Monitoring Platform Receives FDA Clearance CARESCAPE Canvas builds on GE HealthCare\u2019s 50+ years of clinical excellence and provides a unified patient monitoring solution that is reliable, flexible, scalable and intuitive to use CHICAGO&#8211;(BUSINESS WIRE)&#8211; GE HealthCare (Nasdaq: GEHC) today announced US FDA 510(k) clearance of its CARESCAPE Canvas patient monitoring platform for precise, flexible patient care. CARESCAPE Canvas and CARESCAPE ONE are part of an adaptable ecosystem that can easily scale up and scale down monitoring capabilities based on the acuity of each individual patient, delivered on a standardized platform that drives enterprise efficiency and ease of service. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20230420005615\/en\/ CARESCAPE Canvas in the NICU (Photo: &hellip; Continue reading &quot;GE HealthCare\u2019s CARESCAPE Canvas Patient Monitoring Platform Receives FDA Clearance&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-20T13:36:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230420005615\/en\/1769739\/4\/MS-CARESCAPE-Canvas-NICU.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"GE HealthCare\u2019s CARESCAPE Canvas Patient Monitoring Platform Receives FDA Clearance\",\"datePublished\":\"2023-04-20T13:36:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\\\/\"},\"wordCount\":801,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230420005615\\\/en\\\/1769739\\\/4\\\/MS-CARESCAPE-Canvas-NICU.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\\\/\",\"name\":\"GE HealthCare\u2019s CARESCAPE Canvas Patient Monitoring Platform Receives FDA Clearance - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230420005615\\\/en\\\/1769739\\\/4\\\/MS-CARESCAPE-Canvas-NICU.jpg\",\"datePublished\":\"2023-04-20T13:36:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230420005615\\\/en\\\/1769739\\\/4\\\/MS-CARESCAPE-Canvas-NICU.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230420005615\\\/en\\\/1769739\\\/4\\\/MS-CARESCAPE-Canvas-NICU.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GE HealthCare\u2019s CARESCAPE Canvas Patient Monitoring Platform Receives FDA Clearance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GE HealthCare\u2019s CARESCAPE Canvas Patient Monitoring Platform Receives FDA Clearance - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\/","og_locale":"en_US","og_type":"article","og_title":"GE HealthCare\u2019s CARESCAPE Canvas Patient Monitoring Platform Receives FDA Clearance - Market Newsdesk","og_description":"GE HealthCare\u2019s CARESCAPE Canvas Patient Monitoring Platform Receives FDA Clearance CARESCAPE Canvas builds on GE HealthCare\u2019s 50+ years of clinical excellence and provides a unified patient monitoring solution that is reliable, flexible, scalable and intuitive to use CHICAGO&#8211;(BUSINESS WIRE)&#8211; GE HealthCare (Nasdaq: GEHC) today announced US FDA 510(k) clearance of its CARESCAPE Canvas patient monitoring platform for precise, flexible patient care. CARESCAPE Canvas and CARESCAPE ONE are part of an adaptable ecosystem that can easily scale up and scale down monitoring capabilities based on the acuity of each individual patient, delivered on a standardized platform that drives enterprise efficiency and ease of service. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20230420005615\/en\/ CARESCAPE Canvas in the NICU (Photo: &hellip; Continue reading \"GE HealthCare\u2019s CARESCAPE Canvas Patient Monitoring Platform Receives FDA Clearance\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-20T13:36:02+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230420005615\/en\/1769739\/4\/MS-CARESCAPE-Canvas-NICU.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"GE HealthCare\u2019s CARESCAPE Canvas Patient Monitoring Platform Receives FDA Clearance","datePublished":"2023-04-20T13:36:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\/"},"wordCount":801,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230420005615\/en\/1769739\/4\/MS-CARESCAPE-Canvas-NICU.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\/","name":"GE HealthCare\u2019s CARESCAPE Canvas Patient Monitoring Platform Receives FDA Clearance - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230420005615\/en\/1769739\/4\/MS-CARESCAPE-Canvas-NICU.jpg","datePublished":"2023-04-20T13:36:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230420005615\/en\/1769739\/4\/MS-CARESCAPE-Canvas-NICU.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230420005615\/en\/1769739\/4\/MS-CARESCAPE-Canvas-NICU.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcares-carescape-canvas-patient-monitoring-platform-receives-fda-clearance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"GE HealthCare\u2019s CARESCAPE Canvas Patient Monitoring Platform Receives FDA Clearance"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/749654","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=749654"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/749654\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=749654"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=749654"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=749654"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}